Stay updated on Tisotumab Vedotin Continued Treatment in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Tisotumab Vedotin Continued Treatment in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tisotumab Vedotin Continued Treatment in Solid Tumors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:34:23.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the efficacy and safety evaluation of continued treatment with tisotumab vedotin in patients with solid tumors known to express tissue factor.
    Difference
    0.1%
    Check dated 2024-06-06T14:39:14.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying the health conditions and prior treatments required for patients. Previously, it only listed the dates of the last update submissions and verifications.
    Difference
    39%
    Check dated 2024-05-22T20:57:41.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:36:06.000Z thumbnail image

Stay in the know with updates to Tisotumab Vedotin Continued Treatment in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin Continued Treatment in Solid Tumors Clinical Trial page.